The risk of death for patients with COX-2 positive ovarian cancer is 2.8 times that of the patients with COX-2 negative ovarian cancer – COX-2 expression, in this case, is a more predictive prognosis indicator than FIGO stage or histological grade [79]. Here, PTGS2 is linked to ovarian carcinoma.